ZYNERBA PHARMACEUTICALS, INC. Net Cash Provided by (Used in) Financing Activities, Continuing Operations
ZYNERBA PHARMACEUTICALS, INC. reported Net Cash Provided by (Used in) Financing Activities, Continuing Operations of $54.25 million for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-09.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations · last filed 2017-05-09
- ZYNERBA PHARMACEUTICALS, INC. net cash provided by (used in) financing activities, continuing operations for the quarter ending 2017-03-31 was $54.25M.
- ZYNERBA PHARMACEUTICALS, INC. net cash provided by (used in) financing activities, continuing operations for fiscal 2016 was $10.00M, a 76.29% decline from fiscal 2015.
- ZYNERBA PHARMACEUTICALS, INC. net cash provided by (used in) financing activities, continuing operations for fiscal 2015 was $42.19M, a 231.22% increase from fiscal 2014.
- ZYNERBA PHARMACEUTICALS, INC. net cash provided by (used in) financing activities, continuing operations for fiscal 2014 was $12.74M.
| Period end | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 12 month |
|---|---|---|
| 2017-03-31 | $54.25M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $10.00M 10-K · filed 2017-03-27 | |
| 2015-12-31 | $42.19M 10-K · filed 2017-03-27 | |
| 2014-12-31 | $12.74M 10-K · filed 2017-03-27 |